NCT04791670

Brief Summary

Several web portals for patients are available, but an assessment of their performance is scarce. This is of particular interest among candidates for kidney living donation. A crucial aspect of living donation is to provide standardized information about the risks of the procedure. In 2019 it was launched a personalized digital care path for kidney living candidates, which contains information about the donation process and facilitates the communication between clinicians, transplant coordinators, and patients, enabling telemedicine. We aim to investigate living donor candidates' experience with the Health Village web portal and the digital care path for living donor candidates. The secondary aim is to investigate their attitude of living donor candidates to eHealth services.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
122

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Mar 2021

Shorter than P25 for all trials

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2021

Completed
6 days until next milestone

First Submitted

Initial submission to the registry

March 7, 2021

Completed
3 days until next milestone

First Posted

Study publicly available on registry

March 10, 2021

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2021

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2021

Completed
Last Updated

March 10, 2021

Status Verified

March 1, 2021

Enrollment Period

2 months

First QC Date

March 7, 2021

Last Update Submit

March 7, 2021

Conditions

Keywords

eHealthvalue-based healthcare

Outcome Measures

Primary Outcomes (2)

  • Patient´s experience

    Measured with Likert scale

    4 months

  • Patient´s e-Health literature

    Measured with Likert scale

    4 months

Secondary Outcomes (1)

  • Gender differences

    4 months

Interventions

The surveys will include general data, the type of electronic devices in possession and the purpose of use. eHealth literacy will be assessed with the eHeals questionnaire. Platform's ease of use will be assessed with the System Usability Scale, and participants´ opinion about the digital path utility with six questions. These items will be answered with a Likert-scale. Finally, we added an open question for qualitative analysis.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All living donor candidates who contacted the living donor transplant coordinator, and were considered initially suitable for kidney donation.

You may qualify if:

  • Living donor candidates from Helsinki area, from 2019 onwards

You may not qualify if:

  • Living donor candidates from other areas of the country
  • non-Finnish speakers

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (2)

  • Ortiz F, Grasberger J, Ekstrand A, Helantera I, Giunti G. Interactive Health Technology Tool for Kidney Living Donor Assessment to Standardize the Informed Consent Process: Usability and Qualitative Content Analysis. JMIR Form Res. 2024 Jul 9;8:e47785. doi: 10.2196/47785.

  • Ortiz F, Giunti G. Usability assessment of an interactive health technology for kidney living donors: protocol for a prospective cross-sectional survey. BMJ Open. 2022 Jan 3;12(1):e051166. doi: 10.1136/bmjopen-2021-051166.

MeSH Terms

Interventions

Longitudinal Studies

Intervention Hierarchy (Ancestors)

Cohort StudiesEpidemiologic StudiesEpidemiologic Study CharacteristicsEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Study Officials

  • Fernanda Ortiz, PhD, MD

    Helsinki University Central Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Fernanda Ortiz, PhD, MD

CONTACT

Guido Giunti, PhD, MD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Nephrologist

Study Record Dates

First Submitted

March 7, 2021

First Posted

March 10, 2021

Study Start

March 1, 2021

Primary Completion

May 1, 2021

Study Completion

October 1, 2021

Last Updated

March 10, 2021

Record last verified: 2021-03